RAD51 is involved in repair of damage associated with DNA replication in mammalian cells

Journal of Molecular Biology

Volumn 328, Issue 3, 2003, Pages 521-535

  Lundin, Cecilia ^a   Schultz, Niklas ^a   Arnaudeau, Catherine ^a,d   Mohindra, Atul ^b   Hansen, Lasse Tengbjerg ^c   Helleday, Thomas ^a,b  

^a STOCKHOLM UNIVERSITY   (Sweden)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d Institute for Cancer Research   (France)

Author keywords

DNA double strand breaks; Homologous recombination; Mammalian cells; RAD51; Stalled DNA replication forks

Indexed keywords

DOUBLE STRANDED DNA; ETOPOSIDE; HYDROXYUREA; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; RAD51 PROTEIN; THYMIDINE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL LINE; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; DNA REPLICATION; DNA STRAND BREAKAGE; GAMMA RADIATION; GENE OVEREXPRESSION; GENE REPRESSION; HOMOLOGOUS RECOMBINATION; NONHUMAN; PRIORITY JOURNAL;

ESCHERICHIA COLI; EUKARYOTA; MAMMALIA;

EID: 0037414420     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2836(03)00313-9     Document Type: Article

References (70)

1. Hoeijmakers J.H. Genome maintenance mechanisms for preventing cancer. Nature. 411:2001;366-374.
2. Van Gent D.C., Hoeijmakers J.H., Kanaar R. Chromosomal stability and the DNA double-stranded break connection. Nature Rev. Genet. 2:2001;196-206.
3. Baumann P., West S.C. Role of the human RAD51 protein in homologous recombination and double-stranded-break repair. Trends Biochem Sci. 23:1998;247-251.
4. Baumann P., Benson F.E., West S.C. Human Rad51 protein promotes ATP-dependent homologous pairing and strand transfer reactions in vitro. Cell. 87:1996;757-766.
5. Lim D.S., Hasty P. A mutation in mouse rad51 results in an early embryonic lethal that is suppressed by a mutation in p53. Mol. Cell. Biol. 16:1996;7133-7143.
6. Tsuzuki T., Fujii Y., Sakumi K., Tominaga Y., Nakao K., Sekiguchi M., et al. Targeted disruption of the Rad51 gene leads to lethality in embryonic mice. Proc. Natl Acad. Sci. USA. 93:1996;6236-6240.
7. Sonoda E., M S., Sasaki J.M., Buerstedde O., Bezzubova A., Shinohara H., Ogawa M., et al. Rad51-deficient vertebrate cells accumulate chromosomal breaks prior to cell death. EMBO J. 17:1998;598-608.
8. Michel B., Fores M.-J., Viguera E., Grompone G., Seigneur M., Bidnenko V. Rescue of arrested replication forks by homologous recombination. Proc. Natl Acad. Sci. USA. 98:2001;8461-8468.
9. Saintigny Y., Delacote F., Vares G., Petitot F., Lambert S., Averbeck D., Lopez B.S. Characterization of homologous recombination induced by replication inhibition in mammalian cells. EMBO J. 20:2001;3861-3870.
10. Lundin C., Erixon K., Arnaudeau C., Schultz N., Jenssen D., Meuth M., Helleday T. Different roles for non-homologous end joining and homologous recombination following replication arrest in mammalian cells. Mol. Cell Biol. 22:2002;5869-5878.
11. Xia S.J., Shammas M.A., Shmookler Reis R.J. Elevated recombination in immortal human cells is mediated by HsRAD51 recombinase. Mol. Cell Biol. 17:1997;7151-7158.
12. Magnusson K.P., Sandstrom M., Stahlberg M., Larsson M., Flygare J., Hellgren D., et al. p53 splice acceptor site mutation and increased HsRAD51 protein expression in Bloom's syndrome GM1492 fibroblasts. Gene. 246:2000;247-254.
13. Bertrand P., Rouillard D., Boulet A., Levalois C., Soussi T., Lopez B.S. Increase of spontaneous intrachromosomal homologous recombination in mammalian cells expressing a mutant p53 protein. Oncogene. 14:1997;1117-1122.
14. Mekeel K.L., Tang W., Kachnic L.A., Luo C.M., DeFrank J.S., Powell S.N. Inactivation of p53 results in high rates of homologous recombination. Oncogene. 14:1997;1847-1857.
15. Tang W., Willers H., Powell S.N. p53 directly enhances rejoining of DNA double-strand breaks with cohesive ends in gamma-irradiated mouse fibroblasts. Cancer Res. 59:1999;2562-2565.
16. Sturzbecher H.W., Donzelmann B., Henning W., Knippschild U., Buchhop S. p53 is linked directly to homologous recombination processes RAD51/RecA protein interaction. EMBO J. 15:1996;1992-2002.
17. Jimenez G.S., Nister M., Stommel J.M., Beeche M., Barcarse E.A., Zhang X.Q., et al. A transactivation-deficient mouse model provides insights into Trp53 regulation and function. Nature Genet. 26:2000;37-43.
18. Kanamoto T., Hellman U., Heldin C.H., Souchelnytskyi S. Functional proteomics of transforming growth factor-beta1-stimulated Mv1Lu epithelial cells: Rad51 as a target of TGFbeta1-dependent regulation of DNA repair. EMBO J. 21:2002;1219-1230.
19. Sharan S.K., Morimatsu M., Albrecht U., Lim D.S., Regel E., Dinh C., et al. Embryonic lethality and radiation hypersensitivity mediated by RAD51 in mice lacking BRCA2. Nature. 386:1997;804-810.
20. Scully R., Chen J., Plug A., Xiao Y., Weaver D., Feunteun J., et al. Association of BRCA1 with RAD51 in mitotic and meiotic cells. Cell. 88:1997;265-275.
21. Ludwig T., Chapman D.L., Papaioannou V.E., Efstratiadis A. Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53, Brca2/p53 nullizygous embryos. Genes Dev. 11:1997;1226-1241.
22. Suzuki A., de la Pompa J.L., Hakem R., Elia A., Yoshida R., Mo R., et al. Brca2 is required for embryonic cellular proliferation in the mouse. Genes Dev. 11:1997;1242-1252.
23. Patel K.J., Yu V.P., Lee H., Corcoran A., Thistlethwaite F.C., Evans M.J., et al. Involvement of Brca2 in DNA repair. Mol. Cell. 1:1998;347-357.
24. Davies A.A., Masson J.Y., McIlwraith M.J., Stasiak A.Z., Stasiak A., Venkitaraman A.R., West S.C. Role of BRCA2 in control of the RAD51 recombination and DNA repair protein. Mol. Cell. 7:2001;273-282.
25. Wong A.K., Pero R., Ormonde P.A., Tavtigian S.V., Bartel P.L. RAD51 interacts with the evolutionarily conserved BRC motifs in the human breast cancer susceptibility gene brca2. J. Biol. Chem. 272:1997;31941-31944.
26. Chen C.F., Chen P.L., Zhong Q., Sharp Z.D., Lee W.H. Expression of BRC repeats in breast cancer cells disrupts the BRCA2-Rad51 complex and leads to radiation hypersensitivity and loss of G(2)/M checkpoint control. J. Biol. Chem. 274:1999;32931-32935.
27. Chen P.L., Chen C.F., Chen Y., Xiao J., Sharp Z.D., Lee W.H. The BRC repeats in BRCA2 are critical for RAD51 binding and resistance to methyl methanesulfonate treatment. Proc. Natl Acad. Sci. USA. 95:1998;5287-5292.
28. Kraakman-van der Zwet M., Overkamp W.J., van Lange R.E., Essers J., van Duijn-Goedhart A., Wiggers J., et al. Brca2 (XRCC11) deficiency results in radioresistant DNA synthesis and a higher frequency of spontaneous deletions. Mol. Cell Biol. 22:2002;669-679.
29. Moynahan M.E., Pierce A.J., Jasin M. BRCA2 is required for homology-directed repair of chromosomal breaks. Mol. Cell. 7:2001;263-272.
30. Larminat F., Germanier M., Papouli E., Defais M. Deficiency in BRCA2 leads to increase in non-conservative homologous recombination. Oncogene. 21:2002;5188-5192.
31. Venkitaraman A.R. Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell. 108:2002;171-182.
32. Kato M., Yano K., Matsuo F., Saito H., Katagiri T., Kurumizaka H., et al. Identification of Rad51 alteration in patients with bilateral breast cancer. J. Hum. Genet. 45:2000;133-137.
33. Gonzalez R., Silva J.M., Dominguez G., Garcia J.M., Martinez G., Vargas J., et al. Detection of loss of heterozygosity at RAD51, RAD52, RAD54 and BRCA1 and BRCA2 loci in breast cancer: pathological correlations. Br. J. Cancer. 81:1999;503-509.
34. Maacke H., Jost K., Opitz S., Miska S., Yuan Y., Hasselbach L., et al. DNA repair and recombination factor Rad51 is over-expressed in human pancreatic adenocarcinoma. Oncogene. 19:2000;2791-2795.
35. Vispé S., Cazaux C., Lesca C., Defais M. Overexpression of RAD51 protein stimulates homologous recombination and increases resistance of mammalian cells to ionizing radiation. Nucl. Acids Res. 26:1998;2859-2864.
36. Arnaudeau C., Helleday T., Jenssen D. The RAD51 protein supports homologous recombination by an exchange mechanism in mammalian cells. J. Mol. Biol. 289:1999;1231-1238.
37. Yanez R.J., Porter A.C. Gene targeting is enhanced in human cells overexpressing hRAD51. Gene Ther. 6:1999;1282-1290.
38. Lambert S., Lopez B.S. Characterization of mammalian RAD51 double strand break repair using non-lethal dominant-negative forms. EMBO J. 19:2000;3090-3099.
39. Kim P.M., Allen C., Wagener B.M., Shen Z., Nickoloff J.A. Overexpression of human RAD51 and RAD52 reduces double-strand break-induced homologous recombination in mammalian cells. Nucl. Acids Res. 29:2001;4352-4360.
40. Huang Y., Nakada S., Ishiko T., Utsugisawa T., Datta R., Kharbanda S., et al. Role for caspase-mediated cleavage of Rad51 in induction of apoptosis by DNA damage. Mol. Cell. Biol. 19:1999;2986-2997.
41. Helleday T., Arnaudeau C., Jenssen D. A partial hprt gene duplication generated by non-homologous recombination in V79 Chinese hamster cells is eliminated by homologous recombination. J. Mol. Biol. 279:1998;687-694.
42. Thelander L., Reichard P. Reduction of ribonucleotides. Annu. Rev. Biochem. 48:1979;133-158.
43. Bianchi V., Pontis E., Reichard P. Changes of deoxyribonucleoside triphosphate pools induced by hydroxyurea and their relation to DNA synthesis. J. Biol. Chem. 261:1986;16037-16042.
44. Bjursell G., Reichard P. Effects of thymidine on deoxyribonucleoside triphosphate pools and deoxyribonucleic acid synthesis in Chinese hamster ovary cells. J. Biol. Chem. 248:1973;3904-3909.
45. Anderson R.D., Berger N.A. International Commission for Protection Against Environmental Mutagens and Carcinogens Mutagenicity and carcinogenicity of topoisomerase-interactive agents. Mutat. Res. 309:1994;109-142.
46. Erixon K., Cedervall B. Linear induction of DNA double-strand breakage with X-ray dose, as determined from DNA fragment size distribution. Radiat. Res. 142:1995;153-162.
47. Hand R. Eucaryotic DNA: organization of the genome for replication. Cell. 15:1978;317-325.
48. Jeggo P.A., Caldecott K., Pidsley S., Banks G.R. Sensitivity of Chinese hamster ovary mutants defective in DNA double strand break repair to topoisomerase II inhibitors. Cancer Res. 49:1989;7057-7063.
49. Thacker J., Tambini C.E., Simpson P.J., Tsui L.C., Scherer S.W. Localization to chromosome 7q36.1 of the human XRCC2 gene, determining sensitivity to DNA-damaging agents. Hum. Mol. Genet. 4:1995;113-120.
50. Johnson M.A., Jones N.J. The isolation and genetic analysis of V79-derived etoposide sensitive Chinese hamster cell mutants: two new complementation groups of etoposide sensitive mutants. Mutat. Res. 435:1999;271-282.
51. Tebbs R.S., Zhao Y., Tucker J.D., Scheerer J.B., Siciliano M.J., Hwang M., et al. Correction of chromosomal instability and sensitivity to diverse mutagens by a cloned cDNA of the XRCC3 DNA repair gene. Proc. Natl Acad. Sci. USA. 92:1995;6354-6358.
52. Lees-Miller S.P., Godbout R., Chan D.W., Weinfeld M., Day R.S., Barron G.M., Allalunis-Turner J. Absence of p350 subunit of DNA-activated protein kinase from a radiosensitive human cell line. Science. 267:1995;1183-1185.
53. DiBiase S.J., Zeng Z.C., Chen R., Hyslop T., Curran W.J., Iliakis G. DNA-dependent protein kinase stimulates an independently active, nonhomologous, end-joining apparatus. Cancer Res. 60:2000;1245-1253.
54. Flygare J., Falt S., Ottervald J., Castro J., Dackland A.L., Hellgren D., Wennborg A. Effects of HsRad51 overexpression on cell proliferation, cell cycle progression, and apoptosis. Expt. Cell. Res. 268:2001;61-69.
55. Martin S.J., Reutelingsperger C.P., McGahon A.J., Rader J.A., van Schie R.C., LaFace D.M., Green D.R. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J. Expt. Med. 182:1995;1545-1556.
56. Raderschall E., Bazarov A., Cao J., Lurz R., Smith A., Mann W., et al. Formation of higher-order nuclear Rad51 structures is functionally linked to p21 expression and protection from DNA damage-induced apoptosis. J. Cell. Sci. 115:2002;153-164.
57. Sakahira H., Enari M., Nagata S. Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature. 391:1998;96-99.
58. Arnaudeau C., Miranda E.T., Jenssen D., Helleday T. Inhibition of DNA synthesis is a potent mechanism by which cytostatic drugs induce homologous recombination in mammalian cells. Mutat. Res. 461:2000;221-228.
59. Waga S., Hannon G.J., Beach D., Stillman B. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature. 369:1994;574-578.
60. Van der Bliek A.M., Lincke C.R., Borst P. Circular DNA of 3T6R50 double minute chromosomes. Nucl. Acids Res. 16:1988;4841-4851.
61. Beverley S.M. Estimation of circular DNA size using gamma-irradiation and pulsed-field gel electrophoresis. Anal. Biochem. 177:1989;110-114.
62. 25I decay. Int. J. Radiat. Biol. 59:1991;343-357.
63. Lucas I., Germe T., Chevier-Miller M., Hyrien O. Topoisomerase II can unlink replicating DNA by precatenane removal. EMBO J. 20:2001;6509-6519.
64. Slupianek A., Schmutte C., Tombline G., Nieborowska-Skorska M., Hoser G., Nowicki M.O., et al. BCR/ABL regulates mammalian RecA homologs resulting in drug resistance. Mol. Cell. 8:2001;795-806.
65. Higgins N.P., Kato K., Strauss B. A model for replication repair in mammalian cells. J. Mol. Biol. 101:1978;417-425.
66. Postow L., Ullsperger C., Keller R.W., Bustamante C., Vologodskii A.V., Cozzarelli N.R. Positive torsional strain causes the formation of a four-way junction at replication forks. J. Biol. Chem. 276:2001;2790-2796.
67. Zou H., Rothstein R. Holliday junctions accumulate in replication mutants via a RecA homolog-independent mechanism. Cell. 90:1997;87-96.
68. Dare E., Zhang L.H., Jenssen D. Characterization of mutants involving partial exon duplications in the hprt gene of Chinese hamster V79 cells. Somat. Cell. Mol. Genet. 22:1996;201-210.
69. Pierce A.J., Johnson R.D., Thompson L.H., Jasin M. XRCC3 promotes homology-directed repair of DNA damage in mammalian cells. Genes Dev. 13:1999;2633-2638.
70. Brenneman M.A., Weiss A.E., Nickoloff J.A., Chen D.J. XRCC3 is required for efficient repair of chromosome breaks by homologous recombination. Mutat. Res. 459:2000;89-97.